NCM
CELG

Novare Capital Management’s Celgene Corp CELG Stock Holding History

Novare Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-66,739
Closed -$5.97M – 157
2018
Q3 		$5.97M Buy
66,739
+10,470
+19% +$925K 0.95% 44
2018
Q2 		$4.47M Buy
56,269
+510
+0.9% +$42.3K 0.76% 55
2018
Q1 		$4.97M Buy
55,759
+3,715
+7% +$357K 0.87% 48
2017
Q4 		$5.43M Buy
52,044
+3,265
+7% +$368K 0.92% 42
2017
Q3 		$7.11M Buy
48,779
+260
+0.5% +$35.4K 1.25% 20
2017
Q2 		$6.3M Buy
48,519
+275
+0.6% +$33.7K 1.42% 27
2017
Q1 		$6M Buy
48,244
+345
+0.7% +$41.3K 1.39% 26
2016
Q4 		$5.54M Buy
47,899
+5,195
+12% +$579K 1.36% 26
2016
Q3 		$4.46M Buy
42,704
+23,435
+122% +$2.54M 1.17% 38
2016
Q2 		$1.9M Buy
19,269
+14,909
+342% +$1.54M 0.51% 72
2016
Q1 		$436K Sell
4,360
-10,370
-70% -$1.07M 0.12% 93
2015
Q4 		$1.76M Hold
14,730
– – 0.48% 66
2015
Q3 		$1.59M Hold
14,730
– – 0.44% 70
2015
Q2 		$1.71M Sell
14,730
-200
-1% -$22.9K 0.42% 68
2015
Q1 		$1.72M Buy
14,930
+40
+0.3% +$4.78K 0.43% 66
2014
Q4 		$1.67M Sell
14,890
-300
-2% -$31.6K 0.41% 69
2014
Q3 		$1.44M Sell
15,190
-6,930
-31% -$625K 0.35% 74
2014
Q2 		$1.9M Hold
22,120
– – 0.46% 69
2014
Q1 		$1.54M Hold
22,120
– – 0.41% 72
2013
Q4 		$1.87M Hold
22,120
– – 0.52% 68
2013
Q3 		$1.71M Buy
22,120
+120
+0.5% +$8.41K 0.53% 67
2013
Q2 		$1.29M Buy
+22,000
New +$1.32M 0.43% 71

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Novare Capital Management's CELG Position: Q4 2018 in Review

Novare Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 66,739 shares — an estimated $5.97M sold.

Novare Capital Management first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $7.11M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Novare Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Novare Capital Management sold 66,739 Celgene Corp shares in Q4 2018, an estimated $5.97M.
  • Novare Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Novare Capital Management's Celgene Corp position peaked at $7.11M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Novare Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.